Generalist · VC Firm

Khosla Ventures

Khosla Ventures takes opportunistic, contrarian early bets on quantum (Quoherent room-temperature qubits, Menten AI quantum-assisted drug discovery), backing technically ambitious founders even before quantum hits VC consensus.

Active Menlo Park, United StatesFounded 2004

Investment thesis

Khosla Ventures is a Menlo Park firm founded in 2004 by Sun Microsystems co-founder Vinod Khosla, known for bold science-driven bets across AI (OpenAI first investor), climate (Commonwealth Fusion, LanzaTech), healthcare, fintech (Stripe, Affirm, DoorDash) and frontier tech. The firm closed $3.1B across three funds in November 2023 including a $1.6B eighth flagship.

In quantum, exposure is tangential rather than thesis-led: early seed investments in Menten AI ($4M seed for quantum-powered peptide drug discovery) and Quoherent ($4.7M seed for room-temperature solid-state qubits, alongside Morpheus Ventures and Draper Associates). Also historically backed QuantumScape (solid-state batteries, not quantum computing, a name overlap).

Value-add centers on Khosla's unparalleled Silicon Valley network and technical credibility in deep-science sectors, plus patient capital willingness.

Differentiated as a frontier-tech platform where quantum fits within a broader deep-science portfolio thesis rather than as a dedicated vertical.

Anti-thesis

The patterns that trigger a fast no with this fund.

  1. Vinod has publicly stated AI captures 80%+ of near-term value and that quantum is 10+ years from commercial relevance, signaling appetite is limited to one or two trophy bets, not a portfolio
  2. Khosla's burn-tolerance is high but exit-discipline is real, quantum's lack of M&A comps (only IonQ / Rigetti SPACs as exits, both underwater) makes DPI math unattractive vs. AI infra where strategics are paying premium multiples
  3. The fund's black swan framework requires asymmetric upside AND a plausible path to $10B+ outcomes, current quantum revenue ($20 to 50M ARR for leaders) doesn't yet support the denominator
  4. Vinod's preference for founder-scientists who can also sell enterprise software disadvantages most quantum CEOs, who are physicists optimizing for qubit count rather than ARR
  5. Khosla has been vocal that quantum hype outpaces utility and that classical GPU progress (NVIDIA's CUDA-Q) erodes the near-term quantum advantage window for chemistry and optimization use cases

Notable quantum portfolio

Full portfolio
Menten AIQuoherent

Frequent co-investors